Shingrix has been administered in a two-step process. It involved combining two separate vials—a freeze-dried (lyophilized) powder containing the antigen, and a liquid adjuvant, by trained healthcare ...

GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster). The ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

In addition to UBS, GlaxoSmithKline also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued today. However, on July 15, Bank of America Securities maintained a Sell rating on ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.